Le Lézard
Classified in: Science and technology
Subject: Merger/Acquisition

Carenet Completes Acquisition of Health Dialog Assets from Rite Aid


Carenet Health, a trusted partner in transforming the business of healthcare, finalized today its acquisition of clinical support staff and leading technology assets from Health Dialog.

Health plans and health systems will benefit from additional tech-enabled customer experience solutions that emphasize the importance of value-based care, focusing significantly on chronic care management and shared decision-making.

"This acquisition bolsters our already strong AI and machine learning capabilities to further help our 500+ leading healthcare groups evolve their business to meet consumer demands for personalized, forward-thinking care," said John Erwin, Carenet chief executive officer. "With our combined technology platforms, we can continue leveraging our deep data-driven insights to power more seamless engagement experiences for patients and members."

The Health Dialog Pathways Engine predictive analytics and machine learning platform uses 600+ health data points to identify long-term disease trajectory for members, including conditions like asthma, diabetes and heart disease. The tool enables a whole-person, long-term view of an individual's healthcare journey and synchronizes all communications and channels to ensure the best outcomes for clients and consumers. This includes bespoke clinical interventions and action plans to address an individual's unique needs, while also building proactive strategies to delay progression into higher cost stages.

With these added shared decision-making capabilities, Carenet will help clients empower patients with multiple viable treatment options to manage their care and collaborate with their physicians on treatment, while driving measurable cost savings for payers and providers.

This is the latest in a series of strategic acquisitions from Carenet, supplying more integrated, proven solutions for clients looking to streamline their vendor relationships. Health Dialog joins brands such as Inquicker, Beryl Health, Patient Prompt and Academic Health Network as just a sampling of the cutting-edge capabilities Carenet has combined under its robust set of service offerings.

Both Carenet and Health Dialog hold accreditations from the National Committee for Quality Assurance (NCQA) and URAC.

About Carenet

Carenet Health is committed to delivering the business of healthcare through cutting-edge technology, unmatched insights and operational excellence to help payers, providers and health service organizations better meet consumer healthcare needs. For more than 25 years, we have delivered unmatched perspectives to help healthcare companies around the globe solve complex business challenges faster while delivering best-in-class engagement outcomes for consumers. Learn more at www.carenethealth.com.


These press releases may also interest you

at 03:17
Daniels Manufacturing Corporation® (DMC®) is proud to announce the successful acquisition of MCD-Tools GmbH, a leading tool distribution and repair company based near Frankfurt, Germany. DMC's acquisition of MCD-Tools allows DMC to form DMC Europe...

at 03:05
NielsenIQ (NIQ) today announced the availability of NIQ Activate in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. NIQ customers can now take advantage of the productive and trusted Azure cloud...

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
Manhattan Associates today announced that it has been named winner of the VIP Awards' Best Sustainability Initiative category for 2024. Selected from a competitive group of nominees, Manhattan Active® Supply Chain technology was chosen because of...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 03:05
HARMAN, alongside CARIAD, the automotive software company of Volkswagen Group, today announced new collaborations across key industries to enrich the in-cabin experience with newly available apps. This expands the range of apps available in the Group...



News published on and distributed by: